 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Current Price	$72.29
Prev Close	$72.01
Open	$72.19
Dividend Yield	0.00%
50-Day Moving Average	$60.85
Beta	1.51
Avg. Volume	584,694.50
PE Ratio	-27.38

52-Week High	$79.65
52-Week Low	$21.06
Market Capitalization	$3.8B
EPS	-$2.63
Price to Book	6.25
Revenue Per Employee	$432,448.82
Enterprise Value/EBITDA	-13.02

PRTA Prothena Corporation plc

About

Feed

Fundamentals

News